Add time:08/23/2019         Source:sciencedirect.com

Selective N-type Voltage Activated Calcium Channel (VACC) blockers have shown utility in several models of stroke and pain. In the process of searching for small molecules as N-type calcium channel blockers, we have identified a series of N,N-dialkylpeptidylamines (e.g., PD 175069) with potent functional activity at N-type VACC. Further modification of the leucine moiety of PD 175069 with a cyclized ring structure provides a series of novel molecules. Syntheses and pharmacological evaluation of the series are presented.

We also recommend Trading Suppliers and Manufacturers of N-4-Boc-2-piperazinecarboxylic acid (cas 128019-59-0). Pls Click Website Link as below: cas 128019-59-0 suppliers